Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - STOCK-BASED COMPENSATION
Stock-based Compensation GERN - Geron Corporation
19.4 M
LAST VALUE
54.77%
2 YEAR CAGR
24.90%
5 YEAR CAGR
15.87%
10 YEAR CAGR